What does the CRABI acronym stand for in relation to Multiple Myeloma?

Get ready for your Blood, Immune, and Hematologic Disorders Test. Study with detailed flashcards and multiple-choice questions, complete with hints and explanations. Prepare for your exam now!

Multiple Choice

What does the CRABI acronym stand for in relation to Multiple Myeloma?

Explanation:
CRABI expands the classic myeloma findings to include immune vulnerability. It stands for hypercalcemia, renal dysfunction, anemia, bone damage, and immunodeficiency (reduced immune response). In multiple myeloma, malignant plasma cells drive bone resorption, releasing calcium (hypercalcemia); light chains and other factors injure the kidneys (renal dysfunction); marrow infiltration lowers red cell production (anemia); they cause osteolytic bone lesions or damage; and immune function is compromised, leading to a reduced ability to fight infections. The option listing hypercalcemia, renal dysfunction, anemia, bone damage, and reduced immune response aligns with these components.

CRABI expands the classic myeloma findings to include immune vulnerability. It stands for hypercalcemia, renal dysfunction, anemia, bone damage, and immunodeficiency (reduced immune response). In multiple myeloma, malignant plasma cells drive bone resorption, releasing calcium (hypercalcemia); light chains and other factors injure the kidneys (renal dysfunction); marrow infiltration lowers red cell production (anemia); they cause osteolytic bone lesions or damage; and immune function is compromised, leading to a reduced ability to fight infections. The option listing hypercalcemia, renal dysfunction, anemia, bone damage, and reduced immune response aligns with these components.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy